Enemmän aikaa tavoitealueella2, , ympäri vuorokauden.

MiniMed™ 780G -‍järjestelmä säätelee automaattisesti  insuliinin annostelua ja korjaa korkeita glukoosiarvoja 5 minuutin välein, 24/7, ilman sormenpäämittauksia. 

0
%
aika tavoitealueella3
Järjestelmän käyttäjien
0
%
aika tavoitealueella

öisin on keskimäärin4, 

MiniMed™ 780G system

MiniMed™ 780G -järjestelmä

Nyt saatavilla yli 2-vuotiaille diabetesta sairastaville lapsille sekä raskaana oleville naisille.

MiniMed™ 780G system

Harkitsetko automaattista insuliinipumppu­järjestelmää?

Insuliinipumppua valittaessa on tärkeää varmistaa, että se vastaa omia tarpeita ja tuottaa parhaan tuloksen. Tärkeimpiä huomioon otettavia asioita ovat:

  • Aika tavoitealueella (TIR):
    Prosenttiosuus ajasta, jolloin glukoosiarvo on tavoitealueella. Korkeampi TIR vähentää komplikaatioita, kuten silmävaurioita (retinopatiaa), sydän- ja munuaissairauksia.5
  • Kuormituksen vähentäminen:
    Saavuta enemmän tekemällä vähemmän. Pumpun tulisi auttaa sinua pysymään tavoitealueella, vaikka hiilihydraattien laskeminen ei olisikaan tarkkaa.6
MiniMed™ 780G system

Elämä on todella paljon parempaa uuden pumppuni kanssa. 

Talha

6-vuotias tyypin 1 diabeetikko, käyttää MiniMed™ 780G -järjestelmää

Nyt saatavilla yli 2-vuotiaille diabetesta sairastaville lapsille.

SmartGuard™-teknologiaa

Edistyksellisin insuliinipumppu järjestelmämme sisältää SmartGuard™-teknologiaa

SmartGuard™-teknologia ennakoi jatkuvasti insuliinin tarvetta, säätelee insuliinin annostelua ja korjaa korkeita glukoosiarvoja automaattisesti  suojaten samalla matalilta arvoilta.1 Meal Detection™ -ateriantunnistusteknologian ansiosta järjestelmä voi tunnistaa unohtuneen ateria-annoksen ja annostella tarvittaessa enemmän insuliinia aterian jälkeisten korkeiden arvojen korjaamiseksi.

Aterian tunnistus
Kun järjestelmä tunnistaa aterian,
se annostelee suuremman
automaattisen korjausboluksen.

Aterian tunnistus Kun järjestelmä tunnistaa aterian, se annostelee suuremman automaattisen korjausboluksen 3.9 mmol 11:00 13:00 8:00 10 mmol
3.9 mmol 11:00 13:00 8:00 10 mmol

Glukoosiarvo

Basalinsuliini

Automaattinen korjausbolus

Aterian tunnistus

Vain havainnollistamistarkoituksiin.

Mitä sinun pitäisi tietää MiniMed™ 780G -järjestelmästä

Edistynyt algoritmi:

algoritmi mukautuu sinuun ja tarjoaa muita järjestelmiä enemmän aikaa tavoitealueella.7

Pukeudu haluamallasi tavalla:

voit piilottaa pumpun tai jättää sen esille asuvalintasi mukaan.

Ei päivittäistä latausta

toisin kuin muut pumput, MiniMed™ 780G -pumppu ei vaadi latausta.

Mahdollisuus irrottamiseen 

voit irrottaa pumpun eri aktiviteetteja varten jopa tunnin ajaksi.

Vedenpitävä muotoilu 

Kestävä ja helppokäyttöinen pumppu.

Luotettu ympäri Eurooppaa

MiniMed™ 780G -järjestelmä on Euroopan suosituin automaattinen insuliinipumppu ja satojentuhansien ihmisten käytössä.

Vähemmän hh-laskemista

Ainoa järjestelmä Meal Detection™ -ateriantunnistusteknologialla, joka annostelee korjausannoksia automaattisesti  5 minuutin välein

Vähemmän pistoksia

15 päivän Instinct-sensorin ja 7 päivän Extended-infuusiosetin ansiosta vain kuusi asetuskertaa kuukaudessa

Kolme helppokäyttöistä tuotetta samalta
valmistajalta.

MiniMed™ 780G components

MiniMed™ 780G -‍järjestelmän osat

Insuliinipumppu

Vastaanottaa reaaliaikaisia sensorin glukoositietoja laskeakseen insuliiniannoksia ja automaattisia korjauksia.

Annostelee insuliinia automaattisesti  hyödyntämällä SmartGuard™-teknologiaa. Pumppu annostelee enemmän insuliinia, jos glukoosiarvot ovat nousussa, ja vähemmän, jos arvot ovat laskussa.2

MiniMed™ 780G components

MiniMed™ 780G -‍järjestelmän osat

Jatkuva glukoosinseuranta (CGM) – Instinct™-sensori

Pieni ja huomaamaton8 sensori, jossa on kaikki samassa tuotteessa: asetin, lähetin ja sensori. Sensori toimii yhdessä insuliininannostelujärjestelmäsi kanssa, seuraa glukoosiarvojasi jatkuvasti ja sen käyttöikä on jopa 15 vuorokautta.

MiniMed™ 780G components

MiniMed™ 780G -‍järjestelmän osat

Medtronic Extended -‍infuusiosetti

Infuusiosetin käyttöaika on jopa 7 vuorokautta – tarvitset 96%  aiempaa vähemmän pistoksia. Helppo käyttää ja kivuton asettaa – vähentää lisäksi muovijätettä.9

Mietityttääkö letkullinen pumppu?

Letkullinen insuliinipumppu antaa sinulle mahdollisuuden irrottaa se tarvittaessa jopa tunniksi, ja se voidaan sijoittaa joustavasti asuusi sopivaan paikkaan. Voit kantaa sitä ylpeästi vyölläsi tai huomaamattomasti taskussa, valjaissa tai rintaliiveissä – valinta on sinun.

Vertaile MiniMed™ 780G -‍järjestelmää

Järjestelmämme ja kilpailijoiden väliset erot näkee helposti.

MiniMed™ 780G

MiniMed™ 780G

Omnipod 5

Omnipod 5

Ypsomed

Ypsomed

Tandem T-Slim

Tandem T-Slim

Aika tavoitealueella (TIR) 

80%3

67.7%10

72.6%11

71.1%12

Ateriantunnistus

Toimii ilman älypuhelinta

Korkeampi TIR vähentää komplikaatioita, kuten silmävaurioita (retinopatiaa), sydän- ja munuaissairauksia.5

MiniMed™ 780G system

Voin syödä rauhallisin mielin. Saatan ehkä laskea väärin, mutta järjestelmä korjaa tilanteen itsestään. 

Yonatan

MiniMed™ 780G -‍käyttäjä

CareLink app1
Ilmoitus korkeasta tai matalasta
CareLink app2
Nykyinen sensoringlukoosiarvo
CareLink app3
Annostellun insuliinin määrä
CareLink app4
Glukoosikäyrä
CareLink app5
Aika tavoitealueella
CareLink app6
Sensorin glukoosiarvojen keskiarvo

CareLink™ Connect -‍sovellus

Voit jakaa reaaliaikaiset diabetestiedot hoitokumppaneiden kanssa.

Katso tarkemmat tiedot CareLink™ Connect -‍sovelluksen käyttöoppaasta. CareLink™ Connect -‍sovellus edellyttää internet-yhteyttä.

Lataa sovellus nyt:

Google Play Apple Store

MiniMed™ 780G system

Innovaatio, joka muuttaa elämää

Olemme tukenasi helpon ja luotettavan diabeteksen hallinnan saavuttamisessa.

  • StartRight℠-ohjelma
    Perehdytysohjelma on tukenasi pumppuhoidon alkumetreillä.
  • Tuki ja ohjaus
    Käytännön tuoteohjausta koulutushoitajilta sekä tekninen WeCare-tuotetuki.
  • WeCare-sovellus
    Tukea missä ja milloin tahansa. Nopea ja helppo näkymä hoitotiedoista, korvaavien tuotteiden tilaus ja ajankohtaista sisältöä.

Onko älypuhelimesi yhteensopiva Medtronic-sovellusten kanssa?

Tarkista yhteensopivuus

Waterproof capabilitiesThe pump is waterproof at the time of manufacture and when the reservoir and tubing are properly inserted. It is protected against the effects of being underwater to a depth of up to 2.4 meters (8 feet) for up to 30 minutes.
Environmental ConditionsThe MiniMed™ 780G insulin pump system is designed to withstand most conditions encountered in your daily life. Pump storage temperature range is from -4ºF (-20ºC) to 122ºF (50ºC). Air pressure range is from 700 hPa to 1060 hPa (10.2 psi to 15.4 psi).
Attitude Range
  • Pump operating range is from 10.2 psiA (70.33 kPa) to 15.4 psiA (106.18 kPa)
  • Storage range is from 7.2 psiA (49.64 kPa) to 15.4 psiA (106.18 kPa)
Insulin typeRapid-acting U100 insulin (HumalogR and NovoRapidR) that has been prescribed by a healthcare professional.
Bolus delivery

Bolus Speeds

  • Standard : 1.5 units/minute
  • Quick : 15 units/minute

Programming Increments

  • 0.025 units
  • 0.05 units
  • 0.1 units

Max bolus 25 units

Basal Rate Delivery0 to 35 units per hour.
Screen
  • Colour screen with auto-brightness
  • Backlight time out 15 seconds (default), 30 seconds, one minute, three minutes
Battery & PowerThe pump requires one new AA (1.5V) battery. For best results, use a new AA lithium (FR6) battery. The pump also accepts an AA alkaline (LR6) or a fully charged AA NiMH (HR6) nickel-metal hydride rechargeable battery.
Pump memoryAt any time you can review 35 days of pump history.
SizeThe pump dimensions in centimeters are no greater than 10.2 length x 5.8 width x 2.8 depth. The pump dimensions in inches are no greater than 4.0 length x 2.3 width x 1.1 depth. The mass of the insulin pump without battery and consumables is less than 117 grams.
Warranty
  • Insulin pump : 4 years
  • CGM transmitter: 1 year
Compatible products
ReservoirMedtronic reservoir MMT-332A, 3.0 ml (300-units ), Medtronic reservoir MMT0326A, 1.8 ml (180-units)
Infusion SetsMedtronic Diabetes offers a wide range of infusion sets so that you can choose the right one for your comfort and safety. https://www.medtronic-diabetes.co.uk/insulin-pump-therapy/insulin-delivery/infusion-sets
Guardian™ Link 4 TransmitterUsed with your pump for Continuous Glucose Monitoring (CGM). A device that connects to a glucose sensor. The transmitter collects data measured by the sensor and wirelessly sends this data to monitoring devices.
Guardian™ 4 Sensor & transmitterUsed with your pump for Continuous Glucose Monitoring (CGM). Does not require finger pricks for calibration or to make diabetes treatment decisions.  It measures glucose levels every 5 minutes, that’s 288 times a day, and provides you and your pump with up to date information on where your glucose levels are, and where they are heading. This data can also be used by the pump to alert you about upcoming high or low.
AccessoriesThere are many ways to wear your insulin pump. You can attach your pump to your waistband or belt, protect it in your pocket, or even clip it under clothing. See our collection of accessories here. https://www.medtronic-diabetes.co.uk/minimed-insulin-pump-accessories
Accu-Chek® Guide Blood Glucose MeterThe MiniMed™ 780G system comes with a compatible meter. It wirelessly connects to your pump, allowing you to send blood glucose meter readings to your pump. 

Usein kysyttyjä kysymyksiä

The MiniMed™ 780G system is approved for people with type 1 diabetes, age 2 and above. If you would like a stand-alone CGM and not an insulin pump, consider looking into Smart MDI System.

Yes. With the MiniMed™ 780G system you can easily track your glucose levels and view notifications and alerts on your smartphone. Up to 5 care partners can be invited to download the CareLink™ Connect app and view your real-time glucose values on their phones. Available to download at no cost for most iOS and Android smartphones. To see if your smartphone is compatible, see this reference chart.

The MiniMed™ 780G system automatically  adjusts insulin delivery and corrects glucose levels every 5 minutes 24/7, requiring no finger pricks . It features an advanced level of automation for diabetes management, known as SmartGuard™ technology. If your glucose levels are trending high, it gives you more insulin. If they are trending low, it gives you less or no insulin at all. Now it can even correct high glucose levels in cases where carb counts aren’t exact.

The MiniMed™ 780G system, automatically  adjusts delivery of basal insulin based on Continuous Glucose Monitoring (CGM) values. This means that the pump gets glucose readings from Instinct sensor and transmitter automatically, and then delivers a variable rate of insulin, 24 hours a day based on your personal needs. This integrated system – meaning having a pump and a CGM that speak to one another – can help to stabilise your glucose levels and reduce both high and low glucose levels.

When you use an insulin pump, you have a dramatic reduction in injections – by up to 90%.** The infusion set that attaches to your body contains a small, flexible plastic cannula that is inserted to be placed under the skin and changed every 2-3 days. A CGM glucose sensor is inserted every 7 days. Using the SmartGuard™ feature does not completely replace finger pricks but you will likely check your BG less frequently. Sensor readings are taken from your interstitial fluid (fluid surrounding the cells in your tissue) and not your blood, you still need to test using a BG meter. With Guardian™ 4 sensor and transmitter a blood glucose reading is needed when you first enter SmartGuard™ feature, otherwise no finger pricks are required. If glucose alerts and CGM readings do not match your symptoms, use a blood glucose meter to make diabetes treatment decisions. It is important to know that all blood glucose values entered & accepted are used for calibration. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
*Assumes four injections per day for 30 days and one infusion set change every two to three days.

*At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth up to 2.4 meters (8 feet) for up to 30 minutes. Although it’s designed to be waterproof, drops and bumps that occur over time can make it more vulnerable to damage from water. We recommend removing your pump before swimming or bathing. CGM readings may not be transmitted from the sensor to the pump while in water.

  1. Get started by contacting us https://www.medtronic-diabetes.com/en-gb/contact so we can have someone follow up with you. We will help answer any questions, discuss out-of-pocket costs, if you plan to self fund sensors.
  2. Once the system is purchased and shipped, we will work with you to schedule your training. We have a robust technical support team who will help conduct an in-person training. (With the use of CGM and SmartGuard™ tech. You may need a few training sessions.)
  3. Once you’re trained, we will continue to support you throughout your journey with us. We will provide ongoing educational resources and also offer a dedicated Technical Support team who are available 24/7.

If you are a current customer, contact us https://www.medtronic-diabetes.com/en-gb/contact-medtronic-diabetes/product - to discuss your options for upgrading.

If you are a healthcare professional we encourage you to visit https://hcp.medtronic-diabetes.com/en-GB

Viitteet

  1. dQ&A US Patient Voice Q2 2025. p. 77. n=2152. Data on file. Abbott Diabetes Care, Inc.
  2. Choudhary P, et al. Diabetes Technol Ther 2024; 26 (Suppl. 3): S32-S37.
  3. Arrieta A, et al. Diabetes Obes Metab. 2022; doi: 10.1111/dom.14714. Mean 80% TIR is reached using the recommended optimal settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
  4. McVean, et al. Diabetes Obes Metab. 2026;28(3):2456-2460
  5. De Meulemeester J. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia. 2024;67(8):1527-1535. doi:10.1007/s00125-024-06171-y
  6. Petrovski G, et al. Diabetes Care 2023;46(3):544–550
  7. Di Molfetta S, Di Gioia L, Caruso I, et al. Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis. Diabetes Metab Res Rev. 2024;40(6):e3842. doi:10.1002/dmrr.3842
  8. Data on file, Abbott Diabetes Care, Inc.
  9. Fusselman H, et al. FUSS2015D-P - The Extended Wear Infusion Set - A Design for Plastic Waste Reduction. Virtual Diabetes Technology Meeting. 2020
  10. Alwan et al. (2023) doi: 10.1177/19322968231185348
  11. Kovatchev et al. (2022) doi:10.2337/dc22-1217
  12. Forlenza et al. (2024) doi:10.1089/dia.2023.0578
  13. Wheeler BJ, et al. Acta Diabetol. 2022;59(1):31-37.
  • * Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed based on their experience with Guardian™ 4 sensor.
  • ** Compared to MDI + isCGM
  • ^ Katso tarkemmat tiedot SmartGuard™-ominaisuudesta käyttöoppaasta. Käyttäjän vuorovaikutusta vaaditaan.
  • ^^ A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
  • # Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences. Overnight period: 12:00 AM- 6:00 AM [24:00 h – 06:00 h]. Number of users with ≥10 days of sensor glucose data
  • ∞ Reached using optimal settings. Optimal settings are glucose target at 100 mg/dL (5.5 mmol/L) and Active Insulin Time (AIT) at 2 hours and used >95% of the time
  • § Multiple Daily Injections (3 bolus and 1 basal insulin per day) requires 28 injections per week vs. 1 with Medtronic Extended Infusion Set.
  • ◊ Based on RWE publications.
  • ~ The people with diabetes testimonials relates to the account of an individual's response to the treatment. The account is genuine, typical and documented. However, the individual's response does not provide any indication, guide, warranty or guarantee as to the response other people with diabetes may have to the treatment. The response other people with diabetes have to the treatment could be different. Responses to the treatment discussed can and do vary and specific to the individual people with diabetes.
  • ¥ Refer to Accu-Chek® Guide Link User's Manual
  • 1.dQ&A US Patient Voice Q2 2025. p. 77. n=2152. Data on file. Abbott Diabetes Care, Inc.
  • 2.Choudhary P, et al. Diabetes Technol Ther 2024; 26 (Suppl. 3): S32-S37.
  • 3.Arrieta A, et al. Diabetes Obes Metab. 2022; doi: 10.1111/dom.14714. Mean 80% TIR is reached using the recommended optimal settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
  • 4.McVean, et al. Diabetes Obes Metab. 2026;28(3):2456-2460
  • 5.De Meulemeester J. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia. 2024;67(8):1527-1535. doi:10.1007/s00125-024-06171-y
  • 6.Petrovski G, et al. Diabetes Care 2023;46(3):544–550
  • 7.Di Molfetta S, Di Gioia L, Caruso I, et al. Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis. Diabetes Metab Res Rev. 2024;40(6):e3842. doi:10.1002/dmrr.3842
  • 8.Data on file, Abbott Diabetes Care, Inc.
  • 9.Fusselman H, et al. FUSS2015D-P - The Extended Wear Infusion Set - A Design for Plastic Waste Reduction. Virtual Diabetes Technology Meeting. 2020
  • 10.Alwan et al. (2023) doi: 10.1177/19322968231185348
  • 11.Kovatchev et al. (2022) doi:10.2337/dc22-1217
  • 12.Forlenza et al. (2024) doi:10.1089/dia.2023.0578
  • 13.Wheeler BJ, et al. Acta Diabetol. 2022;59(1):31-37.
  • * Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed based on their experience with Guardian™ 4 sensor.
  • ** Compared to MDI + isCGM
  • ^ Katso tarkemmat tiedot SmartGuard™-ominaisuudesta käyttöoppaasta. Käyttäjän vuorovaikutusta vaaditaan.
  • ^^ A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
  • # Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences. Overnight period: 12:00 AM- 6:00 AM [24:00 h – 06:00 h]. Number of users with ≥10 days of sensor glucose data
  • ∞ Reached using optimal settings. Optimal settings are glucose target at 100 mg/dL (5.5 mmol/L) and Active Insulin Time (AIT) at 2 hours and used >95% of the time
  • § Multiple Daily Injections (3 bolus and 1 basal insulin per day) requires 28 injections per week vs. 1 with Medtronic Extended Infusion Set.
  • ◊ Based on RWE publications.
  • ~ The people with diabetes testimonials relates to the account of an individual's response to the treatment. The account is genuine, typical and documented. However, the individual's response does not provide any indication, guide, warranty or guarantee as to the response other people with diabetes may have to the treatment. The response other people with diabetes have to the treatment could be different. Responses to the treatment discussed can and do vary and specific to the individual people with diabetes.
  • ¥ Refer to Accu-Chek® Guide Link User's Manual
  • ^ Katso tarkemmat tiedot SmartGuard™-ominaisuudesta käyttöoppaasta. Käyttäjän vuorovaikutusta vaaditaan.
  • ^^ A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
  • # Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences. Overnight period: 12:00 AM- 6:00 AM [24:00 h – 06:00 h]. Number of users with ≥10 days of sensor glucose data
  • ∞ Reached using optimal settings. Optimal settings are glucose target at 100 mg/dL (5.5 mmol/L) and Active Insulin Time (AIT) at 2 hours and used >95% of the time

CE-DBA-2600170© 2026 Medtronic. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc.

The sensor shape and appearance, Abbott and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under licence. Sensor image © 2026 Abbott.

*Third–party brands are trademarks of their respective owners.